Immunology

New Markers Revealed for Severe Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic condition that affects an estimated 2.3 million people worldwide. In MS, the sheath covering nerve fibers in the brain and spinal cord becomes damaged, slowing or blocking electrical signals from the brain reaching the eyes, muscles, and other parts of the body. More...03 Oct 2017

Pancreatic Proteins Increase Sensitivity of Type 1 Diabetes Tests
There are approximately 29.1 million people living with diabetes and about 18,000 children in the USA are diagnosed with type 1 diabetes, with diagnoses peaking around the age of 14. The disease is controllable with insulin injections, pumps and constant blood sugar testing. More...27 Sep 2017

Low-Volume Aldosterone Immunoassay Validated for Small Samples
Heart failure is a severe cardiovascular disease in adults and children and is characterized by structural or functional abnormalities of the heart. Heart failure leads to an inappropriate blood circulation and subsequently to an undersupply of metabolizing tissues with oxygen and nutrients. More...26 Sep 2017

IBS Colon Reacts Differently to Bacteria
Irritable bowel syndrome disturbs bowel function and the condition leads to repeated episodes of abdominal pain, and usually gives rise to constipation or diarrhea. Around 10% of people in Sweden suffer from IBS, and it is twice as common among women as among men. More...21 Sep 2017


Blood Inflammatory Molecules Increased in ALS
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal neurodegenerative disease characterized by the degeneration of motor neurons in brain and spinal cord. Only 5% to 10% of ALS cases are explained by a genetic mutation, while 90% to 95% of cases are sporadic, with no known cause. More...06 Sep 2017

Immunoassay May Simplify Screening for Liver Cancer
Researchers have developed a highly portable, low-cost immunoassay technology that enables low limits of detection (LoD) by combining solid-phase microextraction membranes, gold nanoparticle labels, and surface-enhanced Raman scattering. Their prototype device successfully measured a liver cancer biomarker at LoD within only ~2 minutes. The team is also working to lower the cost to ~ USD 3 per test. The assay can likely be easily modified to detect infectious diseases such as tuberculosis, malaria, and dengue fever. More...05 Sep 2017
In Other News
Commercially Available Zika Virus Immunoassays Evaluated
Vitamin D Affects Circulating T Cells in Children
Immune Infiltration Test Predicts Cancer Relapse Risk
Inflammatory Marker Associated with Newborn Amygdala
Immunoassay Biomarkers Evaluated for Preeclampsia Diagnosis
Cytokine Concentration Linked to Chronic Fatigue Syndrome
Three Commercial Tests for Lyme Borreliosis Evaluated
New Biomarkers Provide Diagnostic Tool for AD
New Test Rapidly Diagnoses Preeclampsia
Hormone Receptor Antibody Reagents Assessed for Breast Cancer
Performance of Immunosuppressant Drug Assay Kits Analyzed
Genetic Variation Associated with Influenza Severity Identified
New Test Distinguishes Zika from Similar Viral Infections
Powassan Virus Diagnosed in Patients with Tick-Borne Diseases
Lipid-ELISA Improves Detection of Potential PD Biomarker
Immunoassay Systems Compared for Trisomy Screenings
Optofluidic Device Quantifies CTCs in Blood
Rapid Diagnostic Test for RSV Evaluated
Portable Device Finds Sepsis Infection Markers
Novel Biomarker Identifies Early Clinical CV Disease
CE-Marked Immunoassay Rapidly Detects Infection Biomarkers
Assays Evaluated for Early Diagnosis of Leptospirosis
Toxoplasmosis POC Test Compared to Conventional Testing
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.